annual cash & cash equivalents:
$488.10M+$84.30M(+20.88%)Summary
- As of today (May 29, 2025), BIO annual cash & cash equivalents is $488.10 million, with the most recent change of +$84.30 million (+20.88%) on December 31, 2024.
- During the last 3 years, BIO annual cash & cash equivalents has risen by +$17.32 million (+3.68%).
- BIO annual cash & cash equivalents is now -46.16% below its all-time high of $906.55 million, reached on December 31, 2010.
Performance
BIO Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$521.40M+$33.30M(+6.82%)Summary
- As of today (May 29, 2025), BIO quarterly cash & cash equivalents is $521.40 million, with the most recent change of +$33.30 million (+6.82%) on March 31, 2025.
- Over the past year, BIO quarterly cash & cash equivalents has increased by +$88.12 million (+20.34%).
- BIO quarterly cash & cash equivalents is now -42.49% below its all-time high of $906.55 million, reached on December 31, 2010.
Performance
BIO quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BIO Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.9% | +20.3% |
| 3 y3 years | +3.7% | -35.0% |
| 5 y5 years | -26.1% | -13.6% |
BIO Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.9% | -35.0% | +33.7% |
| 5 y | 5-year | -26.3% | +20.9% | -39.4% | +33.7% |
| alltime | all time | -46.2% | >+9999.0% | -42.5% | >+9999.0% |
BIO Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $521.40M(+6.8%) |
| Dec 2024 | $488.10M(+20.9%) | $488.10M(+18.9%) |
| Sep 2024 | - | $410.38M(+0.9%) |
| Jun 2024 | - | $406.91M(-6.1%) |
| Mar 2024 | - | $433.28M(+7.3%) |
| Dec 2023 | $403.80M(-7.0%) | $403.80M(-11.8%) |
| Sep 2023 | - | $457.85M(+17.4%) |
| Jun 2023 | - | $390.00M(-16.0%) |
| Mar 2023 | - | $464.14M(+6.9%) |
| Dec 2022 | $434.21M(-7.8%) | $434.21M(-16.2%) |
| Sep 2022 | - | $517.94M(-13.2%) |
| Jun 2022 | - | $596.58M(-25.6%) |
| Mar 2022 | - | $802.32M(+70.4%) |
| Dec 2021 | $470.78M(-28.9%) | $470.78M(-45.3%) |
| Sep 2021 | - | $859.90M(+17.3%) |
| Jun 2021 | - | $732.84M(+8.8%) |
| Mar 2021 | - | $673.47M(+1.7%) |
| Dec 2020 | $662.21M(+0.2%) | $662.21M(-21.2%) |
| Sep 2020 | - | $840.33M(+38.3%) |
| Jun 2020 | - | $607.58M(+0.7%) |
| Mar 2020 | - | $603.55M(-8.6%) |
| Dec 2019 | $660.67M(+53.1%) | $660.67M(+17.8%) |
| Sep 2019 | - | $561.07M(-3.4%) |
| Jun 2019 | - | $580.68M(+27.4%) |
| Mar 2019 | - | $455.89M(+5.6%) |
| Dec 2018 | $431.53M(+12.4%) | $431.53M(-0.7%) |
| Sep 2018 | - | $434.52M(+7.8%) |
| Jun 2018 | - | $403.01M(-1.0%) |
| Mar 2018 | - | $407.27M(+6.1%) |
| Dec 2017 | $383.82M(-15.9%) | $383.82M(+16.7%) |
| Sep 2017 | - | $328.89M(+2.3%) |
| Jun 2017 | - | $321.58M(+10.3%) |
| Mar 2017 | - | $291.66M(-36.1%) |
| Dec 2016 | $456.26M(-0.3%) | $456.26M(+9.2%) |
| Sep 2016 | - | $417.94M(-0.2%) |
| Jun 2016 | - | $418.65M(+3.7%) |
| Mar 2016 | - | $403.62M(-11.8%) |
| Dec 2015 | $457.55M(+10.7%) | $457.55M(-9.8%) |
| Sep 2015 | - | $507.33M(+12.7%) |
| Jun 2015 | - | $450.13M(+5.7%) |
| Mar 2015 | - | $425.73M(+3.0%) |
| Dec 2014 | $413.25M(+24.6%) | $413.25M(-2.7%) |
| Sep 2014 | - | $424.59M(+10.4%) |
| Jun 2014 | - | $384.67M(+5.5%) |
| Mar 2014 | - | $364.51M(+9.9%) |
| Dec 2013 | $331.55M(-28.5%) | $331.55M(+13.6%) |
| Sep 2013 | - | $291.79M(-20.5%) |
| Jun 2013 | - | $367.00M(-0.4%) |
| Mar 2013 | - | $368.63M(-20.4%) |
| Dec 2012 | $463.39M(-19.3%) | $463.39M(+8.7%) |
| Sep 2012 | - | $426.46M(-6.6%) |
| Jun 2012 | - | $456.49M(-14.5%) |
| Mar 2012 | - | $533.81M(-7.0%) |
| Dec 2011 | $574.23M(-36.7%) | $574.23M(-14.4%) |
| Sep 2011 | - | $671.03M(+0.1%) |
| Jun 2011 | - | $670.30M(+6.8%) |
| Mar 2011 | - | $627.91M(-30.7%) |
| Dec 2010 | $906.55M(+39.5%) | $906.55M(+43.8%) |
| Sep 2010 | - | $630.64M(+2.7%) |
| Jun 2010 | - | $614.22M(+2.7%) |
| Mar 2010 | - | $598.13M(-8.0%) |
| Dec 2009 | $649.94M(+217.8%) | $649.94M(+17.3%) |
| Sep 2009 | - | $554.18M(+3.9%) |
| Jun 2009 | - | $533.47M(+176.6%) |
| Mar 2009 | - | $192.87M(-5.7%) |
| Dec 2008 | $204.52M(+26.4%) | $204.52M(+5.6%) |
| Sep 2008 | - | $193.63M(+5.4%) |
| Jun 2008 | - | $183.64M(+41.8%) |
| Mar 2008 | - | $129.48M(-20.0%) |
| Dec 2007 | $161.76M(-27.7%) | $161.76M(-65.8%) |
| Sep 2007 | - | $472.79M(+103.4%) |
| Jun 2007 | - | $232.40M(+0.9%) |
| Mar 2007 | - | $230.31M(+3.0%) |
| Dec 2006 | $223.61M | $223.61M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $238.42M(-2.9%) |
| Jun 2006 | - | $245.65M(-7.5%) |
| Mar 2006 | - | $265.59M(-10.5%) |
| Dec 2005 | $296.72M(+51.6%) | $296.72M(+21.6%) |
| Sep 2005 | - | $243.98M(-3.2%) |
| Jun 2005 | - | $252.13M(-20.7%) |
| Mar 2005 | - | $317.90M(+62.4%) |
| Dec 2004 | $195.73M(+199.3%) | $195.73M(+56.4%) |
| Sep 2004 | - | $125.15M(-19.4%) |
| Jun 2004 | - | $155.33M(+9.7%) |
| Mar 2004 | - | $141.55M(+116.5%) |
| Dec 2003 | $65.39M(+135.8%) | $65.39M(-53.5%) |
| Sep 2003 | - | $140.75M(+388.2%) |
| Jun 2003 | - | $28.83M(+14.3%) |
| Mar 2003 | - | $25.22M(-9.1%) |
| Dec 2002 | $27.73M(-41.2%) | $27.73M(-29.3%) |
| Sep 2002 | - | $39.25M(+53.0%) |
| Jun 2002 | - | $25.66M(-42.9%) |
| Mar 2002 | - | $44.95M(-4.6%) |
| Dec 2001 | $47.13M(+237.7%) | $47.13M(+45.8%) |
| Sep 2001 | - | $32.33M(+24.0%) |
| Jun 2001 | - | $26.07M(+160.8%) |
| Mar 2001 | - | $9.99M(-28.4%) |
| Dec 2000 | $13.95M(-18.4%) | $13.95M(+62.5%) |
| Sep 2000 | - | $8.59M(-34.3%) |
| Jun 2000 | - | $13.07M(-14.7%) |
| Mar 2000 | - | $15.32M(-10.4%) |
| Dec 1999 | $17.10M(+69.3%) | $17.10M(+44.9%) |
| Sep 1999 | - | $11.80M(+1.7%) |
| Jun 1999 | - | $11.60M(+45.0%) |
| Mar 1999 | - | $8.00M(-20.8%) |
| Dec 1998 | $10.10M(-6.5%) | $10.10M(+21.7%) |
| Sep 1998 | - | $8.30M(-38.5%) |
| Jun 1998 | - | $13.50M(+7.1%) |
| Mar 1998 | - | $12.60M(+16.7%) |
| Dec 1997 | $10.80M(+14.9%) | $10.80M(+129.8%) |
| Sep 1997 | - | $4.70M(-14.5%) |
| Jun 1997 | - | $5.50M(-48.6%) |
| Mar 1997 | - | $10.70M(+13.8%) |
| Dec 1996 | $9.40M(-36.5%) | $9.40M(-62.8%) |
| Sep 1996 | - | $25.30M(-4.2%) |
| Jun 1996 | - | $26.40M(+46.7%) |
| Mar 1996 | - | $18.00M(+21.6%) |
| Dec 1995 | $14.80M(+289.5%) | $14.80M(+94.7%) |
| Sep 1995 | - | $7.60M(+52.0%) |
| Jun 1995 | - | $5.00M(-15.3%) |
| Mar 1995 | - | $5.90M(+55.3%) |
| Dec 1994 | $3.80M(+22.6%) | $3.80M(-2.6%) |
| Sep 1994 | - | $3.90M(-18.8%) |
| Jun 1994 | - | $4.80M(-15.8%) |
| Mar 1994 | - | $5.70M(+83.9%) |
| Dec 1993 | $3.10M(+14.8%) | $3.10M(+19.2%) |
| Sep 1993 | - | $2.60M(-33.3%) |
| Jun 1993 | - | $3.90M(+2.6%) |
| Mar 1993 | - | $3.80M(+40.7%) |
| Dec 1992 | $2.70M(-43.8%) | $2.70M(+12.5%) |
| Sep 1992 | - | $2.40M(-35.1%) |
| Jun 1992 | - | $3.70M(-27.5%) |
| Mar 1992 | - | $5.10M(+6.3%) |
| Dec 1991 | $4.80M(+140.0%) | $4.80M(+71.4%) |
| Sep 1991 | - | $2.80M(+12.0%) |
| Jun 1991 | - | $2.50M(-24.2%) |
| Mar 1991 | - | $3.30M(+65.0%) |
| Dec 1990 | $2.00M(-31.0%) | $2.00M(-42.9%) |
| Sep 1990 | - | $3.50M(-28.6%) |
| Jun 1990 | - | $4.90M(0.0%) |
| Mar 1990 | - | $4.90M(+69.0%) |
| Dec 1989 | $2.90M(-27.5%) | $2.90M(-21.6%) |
| Sep 1989 | - | $3.70M(+60.9%) |
| Jun 1989 | - | $2.30M(-42.5%) |
| Dec 1988 | $4.00M(+110.5%) | $4.00M(+110.5%) |
| Dec 1987 | $1.90M(-9.5%) | $1.90M(-9.5%) |
| Dec 1986 | $2.10M(-65.0%) | $2.10M(-65.0%) |
| Dec 1985 | $6.00M(+566.7%) | $6.00M(+566.7%) |
| Dec 1984 | $900.00K | $900.00K |
FAQ
- What is Bio-Rad Laboratories annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual cash & cash equivalents year-on-year change?
- What is Bio-Rad Laboratories quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly cash & cash equivalents year-on-year change?
What is Bio-Rad Laboratories annual cash & cash equivalents?
The current annual cash & cash equivalents of BIO is $488.10M
What is the all time high annual cash & cash equivalents for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual cash & cash equivalents is $906.55M
What is Bio-Rad Laboratories annual cash & cash equivalents year-on-year change?
Over the past year, BIO annual cash & cash equivalents has changed by +$84.30M (+20.88%)
What is Bio-Rad Laboratories quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BIO is $521.40M
What is the all time high quarterly cash & cash equivalents for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly cash & cash equivalents is $906.55M
What is Bio-Rad Laboratories quarterly cash & cash equivalents year-on-year change?
Over the past year, BIO quarterly cash & cash equivalents has changed by +$88.12M (+20.34%)